NEW YORK (GenomeWeb News) – Scottish DNA analysis firm Lab901 has raised £2.4 million ($4 million) in equity funding from a group of UK investors, the company said today.

Lab901 plans to use the financing to expand international sales of its ScreenTape analysis platform and to continue to develop its products.

The new funding came from Archangel Informal Investment, Alliance Trust Equity Partners, Scottish Enterprise, Foresight 3 VCT, and TriCapital.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.